Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2017 Feb;24(2):202-226.
doi: 10.1177/1933719116654991. Epub 2016 Sep 27.

Research Priorities for Endometriosis

Peter A W Rogers  1 , G David Adamson  2   3 , Moamar Al-Jefout  4 , Christian M Becker  5 , Thomas M D'Hooghe  6 , Gerard A J Dunselman  7 , Asgerally Fazleabas  8 , Linda C Giudice  3   9   10 , Andrew W Horne  11 , M Louise Hull  12 , Lone Hummelshoj  3   10 , Stacey A Missmer  3   13 , Grant W Montgomery  14 , Pamela Stratton  15 , Robert N Taylor  10   16 , Luk Rombauts  3   10   17 , Philippa T Saunders  18 , Katy Vincent  5 , Krina T Zondervan  5   19 ; WES/WERF Consortium for Research Priorities in Endometriosis
Affiliations

Research Priorities for Endometriosis

Peter A W Rogers et al. Reprod Sci. 2017 Feb.

Abstract

The 3rd International Consensus Workshop on Research Priorities in Endometriosis was held in São Paulo on May 4, 2014, following the 12th World Congress on Endometriosis. The workshop was attended by 60 participants from 19 countries and was divided into 5 main sessions covering pathogenesis/pathophysiology, symptoms, diagnosis/classification/prognosis, disease/symptom management, and research policy. This research priorities consensus statement builds on earlier efforts to develop research directions for endometriosis. Of the 56 research recommendations from the 2011 meeting in Montpellier, a total of 41 remained unchanged, 13 were updated, and 2 were deemed to be completed. Fifty-three new research recommendations were made at the 2014 meeting in Sao Paulo, which in addition to the 13 updated recommendations resulted in a total of 66 new recommendations for research. The research recommendations published herein, as well as those from the 2 previous papers from international consensus workshops, are an attempt to promote high-quality research in endometriosis by identifying and agreeing on key issues that require investigation. New areas included in the 2014 recommendations include infertility, patient stratification, and research in emerging nations, in addition to an increased focus on translational research. A revised and updated set of research priorities that builds on this document will be developed at the 13th World Congress on Endometriosis to be held on May 17-20, 2017, in Vancouver, British Columbia, Canada.

Keywords: consensus report; endometriosis; international workshop; research priorities.

PubMed Disclaimer

Conflict of interest statement

Declaration of Conflicting Interests: The author(s) declared the following potential conflicts of interest with respect to the research, authorship, and/or publication of this article: GDA is the owner of Advanced Reproductive Care, Inc and Ziva, and is a consultant to Bayer Pharma and AbbVie. HA is employed by Juneau Biosciences LLC and has direct financial interest in Juneau Biosciences. CA is a consultant to AbbVie, Actavis, and Bayer Pharma. KC is an employee of AbbVie in which he holds stock and stock options. TMD has served as advisor for Bayer Pharma, Proteomika, Pharmaplex, Astellas, Roche Diagnostics, Actavis. On October 1, 12015, TMD became vice president and head of Global Medical Affairs Infertility for Merck Serono and will continue on a part-time basis his academic appointment as a professor of Reproductive Medicine at the University of Leuven (KU Leuven) in Belgium. AF is an unpaid consultant for Abbvie and a consultant for Allergen. AF is principal investigator for a clinical trial launched by Bayer AG. LCG is an unpaid consultant to AbbVie and Nora Therapeutics. LGG consults to Amgen on nonendometriosis-related matters. LH is an unpaid consultant to AbbVie. KM is an employee of Juneau Biosciences LLC. AP consults for MSD, Merck Serono, has received lecture honoraria from MSD, Orion Pharma, and Gedeon Richter, attended a congress paid for by Ferring and is a founding shareholder in Forendo Pharma Ltd. PAWR holds research grants from and acts as an advisor to Bayer Health Care. LR is an advisor to MSD, Merck Serono, and Ferring. PS is an employee of the NIH. RNT is a consultant to AbbVie. WV-K is an employee of Roche Diagnostics International. KTZ has been a consultant to Bayer Health Care.

References

    1. Rogers PA, D’Hooghe TM, Fazleabas A, et al. Priorities for endometriosis research: recommendations from an international consensus workshop. Reprod Sci. 2009;16(4):335–346. - PMC - PubMed
    1. Rogers PA, D’Hooghe TM, Fazleabas A, et al. Defining future directions for endometriosis research: workshop report from the 2011 World Congress of Endometriosis in Montpellier, France. Reprod Sci. 2013;20(5):483–499. - PMC - PubMed
    1. Becker CM, Laufer MR, Stratton P, et al. World Endometriosis Research Foundation Endometriosis Phenome and Biobanking Harmonisation Project: I. Surgical phenotype data collection in endometriosis research. Fertil Steril. 2014;102(5):1213–1222. - PMC - PubMed
    1. Vitonis AF, Vincent K, Rahmioglu N, et al. World Endometriosis Research Foundation Endometriosis Phenome and biobanking harmonization project: II. Clinical and covariate phenotype data collection in endometriosis research. Fertil Steril. 2014;102(5):1223–1232. - PMC - PubMed
    1. Burney RO, Giudice LC. Pathogenesis and pathophysiology of endometriosis. Fertil Steril. 2012;98(3):511–519. - PMC - PubMed

Publication types